
    
      Patients receiving elective cardiac or thoracic aorta surgery will be monitored for the
      development of postoperative hyperbilirubinemia. Collection of data will include patient
      baseline demographic characteristics, laboratory and echocardiographic findings, procedural
      factors of the surgery, and early postoperative variables. Serial postoperative liver
      function testings will be done during the hospitalization. Postoperative hyperbilirubinemia
      is defined as serum bilirubin level of 3mg/dL.
    
  